Notable Analyst Rating Changes 11/12: (SQNM) (DIS) (KLAC) Upgraded; (GRMN) (JCP) (SD) Downgraded
Tweet
Share
E-mail
Get Alerts SQNM Hot Sheet
Join SI Premium – FREE
UPGRADES
Jefferies upgrades Sequenom (Nasdaq: SQNM) from Hold to Buy with a price target of $7. Click Here for more color.
Citi boosts Walt Disney (NYSE: DIS) from Neutral to Buy.
RBC Capital raises KLA-Tencor (Nasdaq: KLAC) from Underperform to Outperform, moving its price target from $49 up to $58.
Goldman Sachs lifts Ryman Hospitality Properties (NYSE: RHP) from Neutral to Buy, whilst raising its price target from $37 to $38. Click Here for more color.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES
Goldman Sachs drops Garmin Ltd. (Nasdaq: GRMN) from Neutral to Sell, moving its price target from $39 down to $34. Click Here for more color.
Credit Suisse cuts J. C. Penney (NYSE: JCP) from Neutral to Underperform.
Jefferies downgrades Nektar Therapeutics (Nasdaq: NKTR) from Buy to Hold, easing its price target from $10 down to $8. Click Here for more color.
SandRidge Energy (NYSE: SD) lowered by two today:
For daily real-time Downgrades go to http://www.streetinsider.com/downgrades
NEW COVERAGE
Needham & Company assumes Dendreon (Nasdaq: DNDN) at Buy and $7 price target.
Wells Fargo initiates Berry Plastics Group (NYSE: BERY) with an Outperform and $16 to $18 valuation range. Click Here for more color.
Sandler O’Neill begins Medallion Financial (Nasdaq: TAXI) with a Hold rating and $12.50 price target.
Brean Capital starts Intercept Pharmaceuticals (Nasdaq: ICPT) with a Buy and $29 price target.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.
Jefferies upgrades Sequenom (Nasdaq: SQNM) from Hold to Buy with a price target of $7. Click Here for more color.
Citi boosts Walt Disney (NYSE: DIS) from Neutral to Buy.
RBC Capital raises KLA-Tencor (Nasdaq: KLAC) from Underperform to Outperform, moving its price target from $49 up to $58.
Goldman Sachs lifts Ryman Hospitality Properties (NYSE: RHP) from Neutral to Buy, whilst raising its price target from $37 to $38. Click Here for more color.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES
Goldman Sachs drops Garmin Ltd. (Nasdaq: GRMN) from Neutral to Sell, moving its price target from $39 down to $34. Click Here for more color.
Credit Suisse cuts J. C. Penney (NYSE: JCP) from Neutral to Underperform.
Jefferies downgrades Nektar Therapeutics (Nasdaq: NKTR) from Buy to Hold, easing its price target from $10 down to $8. Click Here for more color.
SandRidge Energy (NYSE: SD) lowered by two today:
- Global Hunter Securities from Buy to Neutral, moving its price target from $9 down to $5. Click Here for more color; and
- CapitalOne from Add to Neutral with an $8 price target.
For daily real-time Downgrades go to http://www.streetinsider.com/downgrades
NEW COVERAGE
Needham & Company assumes Dendreon (Nasdaq: DNDN) at Buy and $7 price target.
Wells Fargo initiates Berry Plastics Group (NYSE: BERY) with an Outperform and $16 to $18 valuation range. Click Here for more color.
Sandler O’Neill begins Medallion Financial (Nasdaq: TAXI) with a Hold rating and $12.50 price target.
Brean Capital starts Intercept Pharmaceuticals (Nasdaq: ICPT) with a Buy and $29 price target.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rubrik IPO: 5 key things to know
- Lam Research (LRCX) PT Raised to $1,030 at Needham
- Papua New Guinea to host China, Australia high level visits
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Credit Suisse, Citi, Jefferies & Co, Needham & Company, RBC Capital, Notable Analyst Rating Changes, Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
